Cochrane Abstracts
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Systemic Safety of Bevacizumab Versus Ranibizumab for Neovascular Age-related Macular Degeneration: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438525/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review. Accessed 19 April 2024.
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438525/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review. Accessed April 19, 2024.
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438525/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review
Systemic Safety of Bevacizumab Versus Ranibizumab for Neovascular Age-related Macular Degeneration: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438525/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
ID - 438525
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438525/all/Systemic_safety_of_bevacizumab_versus_ranibizumab_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
